OA05524A - Procédé de préparation de compositions antibiotiques à base de 2-pyrrolidine. - Google Patents

Procédé de préparation de compositions antibiotiques à base de 2-pyrrolidine.

Info

Publication number
OA05524A
OA05524A OA56026A OA56026A OA05524A OA 05524 A OA05524 A OA 05524A OA 56026 A OA56026 A OA 56026A OA 56026 A OA56026 A OA 56026A OA 05524 A OA05524 A OA 05524A
Authority
OA
OAPI
Prior art keywords
pyrrolidine
preparation
compositions based
antibiotic compositions
antibiotic
Prior art date
Application number
OA56026A
Other languages
English (en)
Inventor
William Wellesley Armstrong
Saurabhkumar Jayavantrai Desai
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of OA05524A publication Critical patent/OA05524A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyrrole Compounds (AREA)
OA56026A 1976-01-02 1976-12-29 Procédé de préparation de compositions antibiotiques à base de 2-pyrrolidine. OA05524A (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US05/646,295 US4018889A (en) 1976-01-02 1976-01-02 Oxytetracycline compositions
CA268,177A CA1075603A (fr) 1976-01-02 1976-12-17 Solutions aqueuses, stables de doxycycline dans le 2-pyrrolidone
KR7700012A KR810000900B1 (ko) 1976-01-02 1977-01-06 항생물질 조성제의 안정화 방법

Publications (1)

Publication Number Publication Date
OA05524A true OA05524A (fr) 1981-04-30

Family

ID=27164830

Family Applications (1)

Application Number Title Priority Date Filing Date
OA56026A OA05524A (fr) 1976-01-02 1976-12-29 Procédé de préparation de compositions antibiotiques à base de 2-pyrrolidine.

Country Status (29)

Country Link
US (3) US4018889A (fr)
JP (1) JPS5290616A (fr)
KR (1) KR810000900B1 (fr)
AR (1) AR209242A1 (fr)
AT (1) AT345977B (fr)
BE (1) BE849885A (fr)
BG (1) BG36493A3 (fr)
CA (2) CA1075603A (fr)
CH (1) CH616080A5 (fr)
CS (1) CS205030B2 (fr)
DD (1) DD129997A5 (fr)
DE (1) DE2659152C2 (fr)
DK (1) DK145753C (fr)
EG (1) EG12291A (fr)
FI (1) FI56116C (fr)
FR (1) FR2336937A1 (fr)
GB (1) GB1520197A (fr)
GR (1) GR65305B (fr)
HK (1) HK30181A (fr)
IE (1) IE44767B1 (fr)
IN (1) IN145845B (fr)
KE (1) KE3166A (fr)
LU (1) LU76493A1 (fr)
NL (1) NL166620C (fr)
OA (1) OA05524A (fr)
PT (1) PT66017B (fr)
SE (1) SE435997B (fr)
SU (1) SU1309901A3 (fr)
ZA (1) ZA767689B (fr)

Families Citing this family (102)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4126680A (en) * 1977-04-27 1978-11-21 Pfizer Inc. Tetracycline antibiotic compositions
DE2963584D1 (en) * 1978-08-01 1982-10-21 Ciba Geigy Ag Stable, liquid pharmaceutical formulation, its preparation and use
DE2965917D1 (en) * 1978-12-08 1983-08-25 Beecham Group Plc A process for the preparation of a solid sodium amoxycillin and aqueous solutions thereof
US4259331A (en) * 1979-04-16 1981-03-31 Pfizer Inc. Oxytetracycline compositions
IE49934B1 (en) * 1979-07-02 1986-01-08 Pfizer Long acting sulfonamide injectable compositions
US4303643A (en) * 1979-07-05 1981-12-01 Pfizer Inc. Sulfonamide compositions
ATE3750T1 (de) * 1979-07-05 1983-06-15 Pfizer Inc. Sulfonamidloesungen.
US4386083A (en) * 1980-04-10 1983-05-31 Walter Hacke Injectable oxytetracycline compositions
CA1163197A (fr) * 1980-04-10 1984-03-06 Herman Horn Composes d'oxytetracycline injectables
US4399127A (en) * 1980-04-10 1983-08-16 Diamond Shamrock Corporation Injectable oxytetracycline compositions
US4374826A (en) * 1980-07-21 1983-02-22 Pfizer Inc. Sulfonamide compositions
NL178941C (nl) * 1982-06-15 1986-06-16 Aesculaap Bv Werkwijze voor de bereiding van een waterig oxytetracyclinepreparaat.
US4769232A (en) * 1984-03-22 1988-09-06 Pfizer Inc. Parenteral formulations of indolmycin
IE74244B1 (en) * 1985-10-01 1997-07-16 Bimeda Res Dev Ltd A process for preparing an antibiotic composition
HU194493B (en) * 1985-11-27 1988-02-29 Chinoin Gyogyszer Es Vegyeszet Process for preparing primycin-containing colloidal basic gel and compositions comprising the same
FR2608044B1 (fr) * 1986-12-10 1992-09-11 Sogeval Composition antibiotique aqueuse a usage veterinaire
US4906475A (en) * 1988-02-16 1990-03-06 Paco Pharmaceutical Services Estradiol transdermal delivery system
US6756365B2 (en) * 1991-11-06 2004-06-29 Trustees Of Tufts College Reducing tetracycline resistance in living cells
EP0626171A1 (fr) * 1993-05-26 1994-11-30 Winfried Dörnhöfer Solution injectable à base d'oxytetracycline ou doxycycline contenant de la PVP et de la N-methylpyrrolidone et/ou de la 2-pyrrolidone
ES2130069B1 (es) * 1997-04-10 2000-03-01 Basf Labiana S A Preparacion farmaceutica con liberacion retardada del producto activo.
US20020077276A1 (en) * 1999-04-27 2002-06-20 Fredeking Terry M. Compositions and methods for treating hemorrhagic virus infections and other disorders
ATE323671T1 (de) 1999-09-14 2006-05-15 Tufts College Verfahren zur herstellung von substituierten tetracyclinen mit hilfe von auf übergangsmetalle basierten chemien
US6500812B2 (en) 1999-09-14 2002-12-31 Paratek Pharmaceuticals, Inc. 13-substituted methacycline compounds
US6849615B2 (en) 1999-09-14 2005-02-01 Paratek Pharmaceuticals, Inc. 13-substituted methacycline compounds
US8106225B2 (en) * 1999-09-14 2012-01-31 Trustees Of Tufts College Methods of preparing substituted tetracyclines with transition metal-based chemistries
EP1255565A1 (fr) * 2000-01-13 2002-11-13 MERCK PATENT GmbH Compositions pharmaceutiques contenant de la 2-pyrrolidone en tant qu'agent de solubilisation
CA2397863A1 (fr) 2000-01-24 2001-07-26 Trustees Of Tufts College Composes de tetracycline pour le traitement de troubles afferents au cryptosporidium parvum
EA200201046A1 (ru) 2000-03-31 2003-04-24 Трастис Оф Тафтс Коллидж 7- или 9-замещенные соединения тетрациклина, способ их получения (варианты), фармацевтическая композиция, способ лечения состояния, чувствительного к действию тетрациклина, у млекопитающего и реакционноспособное промежуточное производное
US6642270B2 (en) * 2000-05-15 2003-11-04 Paratek Pharmaceuticals, Inc. 7-substituted fused ring tetracycline compounds
US20040224927A1 (en) * 2000-06-16 2004-11-11 Trustees Of Tufts College 7-N-substituted phenyl tetracycline compounds
US20020132798A1 (en) * 2000-06-16 2002-09-19 Nelson Mark L. 7-phenyl-substituted tetracycline compounds
WO2001098236A2 (fr) * 2000-06-16 2001-12-27 Trustees Of Tufts College Composes de tetracycline 7-phenyl-substituee
US20050143353A1 (en) * 2000-07-07 2005-06-30 Paratek Pharmaceuticals, Inc. 13-Substituted methacycline compounds
US7094806B2 (en) * 2000-07-07 2006-08-22 Trustees Of Tufts College 7, 8 and 9-substituted tetracycline compounds
CN1452611A (zh) 2000-07-07 2003-10-29 塔夫茨大学信托人 13－取代甲烯土霉素化合物
US6624168B2 (en) 2000-07-07 2003-09-23 Trustees Of Tufts College 7,8 and 9-substituted tetracycline compounds
CZ2003343A3 (cs) 2000-07-07 2003-05-14 Trustees Of Tufts College 7-Substituované tetracyklinové sloučeniny
ATE544745T1 (de) 2000-07-07 2012-02-15 Tufts College 9-substituierte minocyclinverbindungen
AU2002250331A1 (en) * 2001-03-13 2002-09-24 Paratek Pharmaceuticals, Inc. 7-pyrollyl tetracycline compounds and methods of use thereof
CZ20032780A3 (cs) 2001-03-13 2004-01-14 Paratek Pharmaceuticals, Inc. 7,9- Substituované tetracyklinové sloučeniny
US7553828B2 (en) 2001-03-13 2009-06-30 Paratek Pharmaceuticals, Inc. 9-aminomethyl substituted minocycline compounds
EP1241160A1 (fr) * 2001-03-13 2002-09-18 Glaxo Group Limited Dérivés de tétracyclines et leur utilisation comme agents antibiotiques
US7045507B2 (en) 2001-03-14 2006-05-16 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds as synergistic antifungal agents
US6841546B2 (en) * 2001-03-14 2005-01-11 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds as antifungal agents
CA2444899C (fr) 2001-04-24 2011-06-21 Paratek Pharmaceuticals, Inc. Composes de tetracycline substitues destines au traitement de la malaria
US8088820B2 (en) * 2001-04-24 2012-01-03 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for the treatment of malaria
US20030181371A1 (en) * 2001-12-28 2003-09-25 Angiotech Pharmaceuticals, Inc. Compositions and methods of using collajolie
AU2003235759A1 (en) * 2002-01-08 2003-07-24 Paratek Pharmaceuticals, Inc. 4-dedimethylamino tetracycline compounds
EP1482926A4 (fr) 2002-03-08 2006-04-12 Paratek Pharm Innc Composes a base de tetracycline a substitution aminomethyle
KR101025400B1 (ko) 2002-03-21 2011-03-28 파라테크 파마슈티컬스, 인크. 치환된 테트라시클린 화합물
US6958161B2 (en) 2002-04-12 2005-10-25 F H Faulding & Co Limited Modified release coated drug preparation
AU2003261161B2 (en) 2002-07-12 2009-09-10 Paratek Pharmaceuticals, Inc 3, 10, and 12a substituted tetracycline compounds
EP2277504A1 (fr) 2002-10-24 2011-01-26 Paratek Pharmaceuticals, Inc. Composes tetracycline substituee servant au traitement du paludisme
CN1732023A (zh) * 2002-12-27 2006-02-08 血管技术国际股份公司 组合物和使用collajolie的方法
US20060287283A1 (en) * 2003-07-09 2006-12-21 Paratek Pharmaceuticals, Inc. Prodrugs of 9-aminomethyl tetracycline compounds
US20050137174A1 (en) 2003-07-09 2005-06-23 Paratek Pharmaceuticals, Inc. Prodrugs of 9-aminomethyl tetracycline compounds
EP2319829A1 (fr) * 2003-07-09 2011-05-11 Paratek Pharmaceuticals, Inc. Composés tétracyclines substitués em position 9
AU2004261143B2 (en) * 2003-07-25 2009-11-05 Allergan Pharmaceuticals International Limited A doxycycline metal complex in a solid dosage form
CA2553510C (fr) 2004-01-15 2012-09-25 Paratek Pharmaceuticals, Inc. Derives a cycle aromatique a provenant de composes de tetracycline
TWI261038B (en) * 2004-08-11 2006-09-01 Bo-Cheng Chen Bicycle gear-shifting handgrip
CA2585418A1 (fr) * 2004-10-25 2006-05-04 Paratek Pharmaceuticals, Inc. 4-aminotetracyclines et procedes d'utilisation
EP2284151A3 (fr) 2004-10-25 2011-09-21 Paratek Pharmaceuticals, Inc. Composés de tétracycline substituée
AU2006206359B2 (en) * 2005-01-21 2011-03-31 Allergan Pharmaceuticals International Limited A tetracycline metal complex in a solid dosage form
EP1848685A1 (fr) 2005-02-04 2007-10-31 Paratek Pharmaceuticals, Inc. Derives 11a, 12 de composes de tetracycline
US7919483B2 (en) * 2005-06-24 2011-04-05 Medicis Pharmaceutical Corporation Method for the treatment of acne
US20080242642A1 (en) 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US7544373B2 (en) * 2007-04-02 2009-06-09 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US20080241235A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US7541347B2 (en) * 2007-04-02 2009-06-02 Medicis Pharmaceutical Coropration Minocycline oral dosage forms for the treatment of acne
US8252776B2 (en) 2007-04-02 2012-08-28 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US8722650B1 (en) 2005-06-24 2014-05-13 Medicis Pharmaceutical Corporation Extended-release minocycline dosage forms
AU2006272698B2 (en) * 2005-07-21 2012-11-01 Paratek Pharmaceuticals, Inc. 10-substituted tetracyclines and methods of use thereof
AU2007208214B2 (en) * 2006-01-24 2013-02-14 Paratek Pharmaceuticals, Inc. Methods of increasing oral bioavailability of tetracyclines
US20070244335A1 (en) * 2006-04-17 2007-10-18 Teva Pharmaceutical Industries Ltd. Isolation of tetracycline derivatives
PT2016045E (pt) * 2006-04-24 2015-02-05 Teva Pharma Forma cristalina de tigeciclina e processos para a sua preparação
US8198470B2 (en) * 2006-04-24 2012-06-12 Teva Pharmaceutical Industries Ltd. Crystalline form II of tigecycline and processes for preparation thereof
EP2537934A3 (fr) * 2006-05-15 2013-04-10 Paratek Pharmaceuticals, Inc. Procédés de régulation de lýexpression des gènes ou produits génétiques utilisant des composés tétracyclines substitués
US8440646B1 (en) 2006-10-11 2013-05-14 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for treatment of Bacillus anthracis infections
US8513223B2 (en) 2006-12-21 2013-08-20 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for treatment of inflammatory skin disorders
BRPI0720569B8 (pt) 2006-12-21 2021-05-25 Paratek Pharm Innc compostos de tetraciclina substituída e uso dos ditos compostos para o tratamento de uma infecção bacteriana, viral ou parasitária
US20080241197A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline dosage forms for the treatment of acne
WO2008127722A1 (fr) 2007-04-12 2008-10-23 Paratek Pharmaceuticals, Inc. Procédés pour le traitement de l'amyotrophie spinale à l'aide de composés tétracyclines.
JP2010525069A (ja) 2007-04-27 2010-07-22 パラテック ファーマシューティカルズ インコーポレイテッド アミノアルキルテトラサイクリン化合物の合成方法および精製方法
ES2386926T3 (es) 2007-07-06 2012-09-06 Paratek Pharmaceuticals, Inc. Métodos para sintetizar minociclina9-sustituida
US20090253660A1 (en) 2008-03-05 2009-10-08 Paratek Pharmaceuticals, Inc. Minocycline Compounds and Methods of Use Thereof
PT2271348T (pt) 2008-03-28 2018-04-16 Paratek Pharm Innc Formulação de comprimido oral de composto de tetraciclina
AU2009236631A1 (en) * 2008-04-14 2009-10-22 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
TW202216656A (zh) * 2008-05-23 2022-05-01 美商Ｐｒｔｋ Ｓｐｖ２公司 四環素化合物之甲苯磺酸鹽及同素異形體
WO2010017310A1 (fr) 2008-08-06 2010-02-11 Medicis Pharmaceutical Corporation Procédé pour le traitement de l'acné, et certaines formes posologiques de celui-ci
AU2009292986A1 (en) * 2008-09-19 2010-03-25 Paratek Pharmaceuticals, Inc. Tetracycline compounds for the treatment of rheumatoid arthritis and related methods of treatment
EP3061460A1 (fr) 2009-04-10 2016-08-31 Tufts Medical Center, Inc. Activation de par-1 par la métalloprotéinase-1 (mmp-1)
CN102970992B (zh) 2010-05-12 2016-07-06 莱姆派克斯制药公司 四环素组合物
JP6574572B2 (ja) 2011-05-12 2019-09-11 パラテック ファーマシューティカルズ インコーポレイテッド （４ｓ，４ａｓ，５ａｒ，１２ａｓ）−４−ジメチルアミノ−３，１０，１２，１２ａ−テトラヒドロキシ−７−［（メトキシ（メチル）アミノ）−メチル］−１，１１−ジオキソ−１，４，４ａ，５，５ａ，６，１１，１２ａ−オクタヒドロ−ナフタセン−２−カルボン酸アミドの結晶塩及びそれを使用する方法
US9561241B1 (en) 2011-06-28 2017-02-07 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for minocycline
WO2015021387A2 (fr) * 2013-08-09 2015-02-12 Britt George N Formulations pour le contrôle et la prévention de maladies parodontales et péri-implantaires et d'autres maladies et affections buccales, et procédés et systèmes d'administration supra- et sub-gingivale pour de telles formulations
CN103536530A (zh) * 2013-10-30 2014-01-29 王玉万 盐酸多西环素长效注射剂及制备方法
US9918998B2 (en) 2015-03-23 2018-03-20 BioPharmX, Inc. Pharmaceutical tetracycline composition for dermatological use
CN104721133B (zh) * 2015-04-14 2018-05-18 四川美嘉龙生物科技有限公司 一种土霉素制剂及制备方法
RU2019113715A (ru) 2016-11-01 2020-12-03 Паратек Фармасьютикалс, Инк. 9-аминометилминоциклиновые соединения и их применение для лечениия внебольничной бактериальной пневмонии(вбп)
CN111343991A (zh) 2017-07-21 2020-06-26 阿尔米雷尔有限责任公司 非炎性病变的治疗
AU2018374490B2 (en) 2017-11-28 2024-05-16 New Matterhorn, Llc Method for producing trehalose employing a trehalose phosphorylase variant
US11426351B2 (en) 2019-12-26 2022-08-30 Sunstar Inc. Process for producing a pharmaceutical composition containing micro particles

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB805026A (en) * 1956-03-02 1958-11-26 Konink Nl Gisten Spiritusfabri Process for enhancing the solubility of medicines in water
GB802111A (en) * 1956-09-25 1958-10-01 Irwin Irville Lubowe Improved non-toxic pesticidal compositions
US2990331A (en) * 1956-11-23 1961-06-27 Pfizer & Co C Stable solutions of salts of tetracyclines for parenteral administration
DE1091287B (de) * 1957-04-09 1960-10-20 Byk Gulden Lomberg Chem Fab Verfahren zur Herstellung stabiler, waessriger Loesungen von Tyrothricin und Subtilin
US2980584A (en) * 1957-10-29 1961-04-18 Pfizer & Co C Parenteral magnesium oxytetracycline acetic or lactic acid carboxamide vehicle preparation
US2987437A (en) * 1958-03-06 1961-06-06 Gen Aniline & Film Corp Nematocidal composition
US3062717A (en) * 1958-12-11 1962-11-06 Pfizer & Co C Intramuscular calcium tetracycline acetic or lactic acid carboxamide vehicle preparation
US3957972A (en) * 1966-05-31 1976-05-18 Koninklijke Nederlandsche Gist-En Spiritusfabriek N.V. Stable solutions of oxytetracycline suitable for parenteral and peroral administration and process of preparation
NL6607516A (fr) * 1966-05-31 1967-12-01
DE1767891C3 (de) * 1968-06-28 1980-10-30 Pfizer Verfahren zur Herstellung von wäßrigen arzneilichen Lösungen für die parenterale, perorale und lokale Anwendung mit einem Gehalt an einem Tetracyclinderivat
US3957980A (en) * 1972-10-26 1976-05-18 Pfizer Inc. Doxycycline parenteral compositions
GB1508601A (en) * 1974-01-19 1978-04-26 Norbrook Labor Ltd Oxytetracycline solution
DK138974B (da) * 1974-02-19 1978-11-27 Ciba Geigy Ag Fremgangsmåde til fremstilling af vandige oxytetracyclinopløsninger til parenteral, peroral og lokal anvendelse.
US3957994A (en) * 1974-12-19 1976-05-18 Nelson Research & Development Company Topical anti-inflammatory composition and method of use
US3969516A (en) * 1974-12-19 1976-07-13 Nelson Research & Development Company Composition and method for treatment of acne
US3932653A (en) * 1974-12-19 1976-01-13 Nelson Research & Development Co. Composition and method for topical administration of griseofulvin
GB1538903A (en) 1975-04-11 1979-01-24 Nelson Res & Dev Carrier for a topically applied physiologically active agent or cosmetic agent

Also Published As

Publication number Publication date
SE7613959L (sv) 1977-07-03
ZA767689B (en) 1977-12-28
DE2659152A1 (de) 1977-07-14
NL166620C (nl) 1981-09-15
ATA971776A (de) 1978-02-15
KE3166A (en) 1981-11-06
IE44767L (en) 1977-07-02
CH616080A5 (fr) 1980-03-14
EG12291A (en) 1978-09-30
HK30181A (en) 1981-07-10
BE849885A (fr) 1977-06-28
SE435997B (sv) 1984-11-05
NL166620B (nl) 1981-04-15
DD129997A5 (de) 1978-03-01
CA1075603A (fr) 1980-04-15
DE2659152C2 (de) 1984-04-05
SU1309901A3 (ru) 1987-05-07
PT66017B (en) 1978-06-19
PT66017A (en) 1977-01-01
CS205030B2 (en) 1981-04-30
FR2336937B1 (fr) 1980-06-27
CA1072012A (fr) 1980-02-19
KR810000900B1 (ko) 1981-08-19
GB1520197A (en) 1978-08-02
FI56116C (fi) 1979-12-10
FR2336937A1 (fr) 1977-07-29
US4081528A (en) 1978-03-28
JPS565368B2 (fr) 1981-02-04
IN145845B (fr) 1979-01-06
US4086332A (en) 1978-04-25
US4018889A (en) 1977-04-19
FI763716A (fr) 1977-07-03
AT345977B (de) 1978-10-10
FI56116B (fi) 1979-08-31
DK584676A (da) 1977-07-03
AR209242A1 (es) 1977-03-31
IE44767B1 (en) 1982-03-24
AU2057176A (en) 1978-09-28
GR65305B (en) 1980-08-01
NL7614470A (nl) 1977-07-05
DK145753B (da) 1983-02-21
DK145753C (da) 1983-08-08
BG36493A3 (en) 1984-11-15
LU76493A1 (fr) 1977-07-05
JPS5290616A (en) 1977-07-30

Similar Documents

Publication Publication Date Title
OA05524A (fr) Procédé de préparation de compositions antibiotiques à base de 2-pyrrolidine.
IT1064386B (it) Procedimento per la fabbricazione di transistori
BE587989A (fr) Procédé de préparation d'agents tensionactifs à base de dérivés de polyalcoylène-glycols.
OA05107A (fr) Procédé de préparation d'une composition antiparasite à base de 5-propylthio-2-benzimidazolecarrbamate de méthyl.
OA05445A (fr) Procédé de préparation de nouvelles pyrimidones.
DK144337C (da) Fremgangsmaade til fremstilling af et antibiotikum betegnet forbindelse 47.444
OA06486A (fr) Procédé de préparation de 9 aminoalkylfluorènes.
OA05096A (fr) Procédé de préparation de composés hétérocycliques.
DK554076A (da) Fremgangsmade til fremstilling af 3,4i-dideoxykanamycin ]
FR2335522A1 (fr) Procede de preparation d'androstene-4 diones-3,17
OA05605A (fr) Procédé de préparation de nouvelles isobutyramides.
OA05668A (fr) Procédé de préparation de nouvelles aryl trifluoroéthylamines.
OA05405A (fr) Procédé de préparation de composés pharmacologiquement actifs.
OA05260A (fr) Procédé de préparation de dérivés d'histidine.
OA04641A (fr) Prcédé de préparation de 3-fluorocéphalosporines.
IT1061454B (it) Processo per la preparazione di 1.2 ossafosfolani
OA05404A (fr) Procédé de préparation de composés pharmocologiquement actifs.
OA06355A (fr) Procédé de préparation de 3-exométhylènecépham-sulfoxydes.
FR2297202A1 (fr) Procede de preparation de mono-(3'-hydroxy)-propionates du 1,3-propane-diol
OA05295A (fr) Procédé de préparation de tétrazoles substitués.
OA05241A (fr) Procédé de préparation d'E-(-glutamyl)-lysine.
IT1065395B (it) Processo per la preparazione di 1,1-dialogeno-4-metil-1,3-pentadieni
OA05675A (fr) Procédé de préparation de dérivés de méthylamine.
IT1064754B (it) Processo per la preparazione di cicloesandioni-(1,3)
OA05390A (fr) Procédé pour la préparation de composition anthelmintique.